February 13, 2025 — IOI Corporation Berhad (IOI), through our German subsidiary KetoLipix Therapeutics GmbH (KetoLipix), is leading pharmaceutical innovation by developing drug therapies for conditions with high unmet medical need, leveraging KetoLipix’s breakthrough ketone ester technology.

You might also be interested in reading CFTC’s Pham Said to Plot Exit, Agency May Be Left Without a Party Majority.